Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | GPR3 | P46089 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 3/20 | 0.32 |
| ▸ | RAB9A | P51151 | 3/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.32 |
| ▸ | PKM | P14618 | 2/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | STAT3 | P40763 | 1/20 | 0.32 |
| ▸ | STAT1 | P42224 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CASP3 | P42574 | 1/20 | 0.31 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.31 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.31 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7542646 | 0.84 | GPR3 (0.34) | MEN1KMT2AATMGPR3NPC1 | |
| SCHEMBL7936607 | 0.84 | GPR3 (0.34) | MEN1KMT2AATMGPR3NPC1 | |
| SCHEMBL30307362 | 0.81 | GPR3 (0.32) | GPR3NPC1RAB9ASMN1; SMN2CASP3 | |
| SCHEMBL20996628 | 0.81 | GPR3 (0.32) | GPR3NPC1RAB9ASMN1; SMN2CASP3 | |
| SCHEMBL7944622 | 0.78 | GPR3 (0.34) | GPR3POLB | |
| SCHEMBL21034911 | 0.77 | PTPN1 (0.37) | MEN1KMT2AATMPOLB | |
| SCHEMBL7632634 | 0.74 | — | — | |
| SCHEMBL20920183 | 0.74 | HTR6 (0.33) | MEN1KMT2ANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL30084515 | 0.73 | PTPN1 (0.34) | — | |
| SCHEMBL21034568 | 0.73 | TSHR (0.36) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10882925-B2 | Catalysts that produce polyethylene with broad, bimodal molecular weight distribution | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2021-01-05 | — | — | US | disclosed |
| US-20190161561-A1 | Catalysts that Produce Polyethylene with Broad, Bimodal Molecular Weight Distribution | EXXONMOBIL CHEMICAL PATENTS INC. | 2019-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10882925-B2 | Catalysts that produce polyethylene with broad, bimodal molecular weight distribution | RPLP0, RPSA, RPS10 | MEN1 1400/4885KMT2A 222/4885ATM 1695/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.